Stephen Kennedy,
Assistant Professor of Biomedical and Chemical Engineering,
University of Rhode Island
Dr. Kennedy is currently an Assistant Professor of Biomedical and Chemical Engineering at the University of Rhode Island. Prof. Kennedy received his B.S., M.S., and Ph.D. in electrical engineering at the University of Wisconsin. During his graduate studies, he was awarded a National Institutes of Health (NIH) Ruth L. Kirschstein Fellowship and a Wisconsin Stem Cell and Regenerative Medicine Fellowship in Interdisciplinary Bioengineering. Prior to attaining a faculty position, Prof. Kennedy conducted his postdoctoral work at Harvard University and the Wyss Institute for Biologically Inspired Engineering under the mentorship of David Mooney. His scientific works have been recognized numerous times by the Bioelectromagnetics Society, ACEA Biosciences, the American Institute for Chemical Engineering (AIChE), and have been published in 54 peer-reviewed journal articles and conference proceedings. These works have been featured as the frontispiece in Advanced Materials and have been highlighted in an article by Materials Today. Dr. Kennedy is the recipient of the NIH National Research Service Award, the Curtis Carl Johnson Memorial Award, the Gerald Holdridge Award for Excellence in Teaching, and a 3M Non-Tenure Faculty Award. Prof. Kennedy is originally from Huntsville, Alabama and currently resides in North Kingstown, Rhode Island with his wife, Sandra, son, Spencer, and geriatric Labrador retriever, Doodles.
Active Materials for Remotely Regulating Complex, Multi-drug Delivery Profiles
Tuesday, 27 March 2018 at 13:30
Add to Calendar ▼2018-03-27 13:30:002018-03-27 14:30:00Europe/LondonActive Materials for Remotely Regulating Complex, Multi-drug Delivery ProfilesSELECTBIOenquiries@selectbiosciences.com
Biological processes are characterized by a high degree of
spatiotemporal complexity and often manifest as a highly choreographed
sequence of biological events. Biomaterials such as hydrogels can
provide the localized deliveries needed to regulate biological
processes. However, they are incapable of regulating multi-drug delivery
profiles with the level of control required to regulate complex
biological processes (i.e., control over the timing, rate, and sequence
of multiple therapeutics). Moreover, the timings, rates, and sequences
delivered for particular therapies must likely be customized for
individual patients and may need to be changed in real-time according to
updated patient prognoses. This necessitates the need for on-demand
regulation over the timings, rates, and sequences of deliveries. Here,
we will present strategies for on-demand, remote control over the
timing, rate, and sequence of therapeutic deliveries from hydrogels
using electrically, magnetically, and ultrasonically active materials.
We will further describe biological scenarios where the deliveries
provided by traditional hydrogels can be greatly improved upon using
remotely activated materials (e.g., wound healing, tissue engineering,
chemotherapies). Finally, we will demonstrate that these remotely active
hydrogel materials have the potential to deliver optimized delivery
schedules in a wide range of therapeutic strategies.
Add to Calendar ▼2018-03-26 00:00:002018-03-27 00:00:00Europe/LondonInnovations in Microfluidics, Biofabrication, Synthetic BiologySELECTBIOenquiries@selectbiosciences.com